Souhaitez-vous accéder aux communiqués récents ?

Wrap Technologies, Inc. to Report Fourth Quarter 2025 and Full Year Financial Results on Thursday, March 26, 2026 at 4:15 p.m. ET

Completed target enrollment in Phase 1 monotherapy dose expansion study of micvotabart pelidotin (MICVO) in 2L+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) in the first...

– Continued Advancement of Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) - Final Analysis upon Reaching 80 Events – – First Patient Dosed in Phase 2 Trial of...

Pennsylvania Dept Advances Non-Lethal Response Strategy with Latest BolaWrap Technology & State’s 1st WrapTactics Learning Management System Implementation

Circle CVI brings advanced vascular analysis to the cvi42 cardiovascular imaging platform with AI-enabled aortic, carotid, and peripheral artery solutions.

Miami, Florida, March 18, 2026 (GLOBE NEWSWIRE) -- Care@Home 4 Life, the pioneering company behind the Care@Home Guarantee™, is proud to announce that it has finalized a strategic partnership...

CNS appoints Jay Varma as Director of Employer Partnerships to expand access to specialized neurological care through employer and health plan ecosystems.

Advancing transformation into a diversified biomedical innovation company with a clear path to cash flow positive Oramed strategic transaction receives shareholder approval; Lifeward gains...

Wrap's combined systems expected to accelerate drone-enabled non-lethal and counter-UAS technologies for law enforcement, public safety, and DHS missions.

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, March 17, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that...